{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34112877",
  "DateCompleted": {
    "Year": "2021",
    "Month": "06",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "12310",
      "10.1038/s41598-021-91625-1"
    ],
    "Journal": {
      "ISSN": "2045-2322",
      "JournalIssue": {
        "Volume": "11",
        "Issue": "1",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "10"
        }
      },
      "Title": "Scientific reports",
      "ISOAbbreviation": "Sci Rep"
    },
    "ArticleTitle": "Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19.",
    "Pagination": {
      "StartPage": "12310",
      "MedlinePgn": "12310"
    },
    "Abstract": {
      "AbstractText": [
        "The novel SARS-CoV-2 virus emerged in December 2019 and has few effective treatments. We applied a computational drug repositioning pipeline to SARS-CoV-2 differential gene expression signatures derived from publicly available data. We utilized three independent published studies to acquire or generate lists of differentially expressed genes between control and SARS-CoV-2-infected samples. Using a rank-based pattern matching strategy based on the Kolmogorov-Smirnov Statistic, the signatures were queried against drug profiles from Connectivity Map (CMap). We validated 16 of our top predicted hits in live SARS-CoV-2 antiviral assays in either Calu-3 or 293T-ACE2 cells. Validation experiments in human cell lines showed that 11 of the 16 compounds tested to date (including clofazimine, haloperidol and others) had measurable antiviral activity against SARS-CoV-2. These initial results are encouraging as we continue to work towards a further analysis of these predicted drugs as potential therapeutics for the treatment of COVID-19."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Le",
        "ForeName": "Brian L",
        "Initials": "BL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Andreoletti",
        "ForeName": "Gaia",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Oskotsky",
        "ForeName": "Tomiko",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA."
          }
        ],
        "LastName": "Vallejo-Gracia",
        "ForeName": "Albert",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          }
        ],
        "LastName": "Rosales",
        "ForeName": "Romel",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Biomedical Sciences Graduate Program, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Yu",
        "ForeName": "Katharine",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Kosti",
        "ForeName": "Idit",
        "Initials": "I"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA."
          }
        ],
        "LastName": "Leon",
        "ForeName": "Kristoffer E",
        "Initials": "KE"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Biomedical Sciences Graduate Program, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Bunis",
        "ForeName": "Daniel G",
        "Initials": "DG"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Shanghai American School, Shanghai, China."
          }
        ],
        "LastName": "Li",
        "ForeName": "Christine",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA."
          }
        ],
        "LastName": "Kumar",
        "ForeName": "G Renuka",
        "Initials": "GR"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          }
        ],
        "LastName": "White",
        "ForeName": "Kris M",
        "Initials": "KM"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA."
          }
        ],
        "LastName": "Garc\u00eda-Sastre",
        "ForeName": "Adolfo",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Medicine, UCSF, San Francisco, CA, USA."
          }
        ],
        "LastName": "Ott",
        "ForeName": "Melanie",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pediatrics, UCSF, San Francisco, CA, USA. marina.sirota@ucsf.edu."
          },
          {
            "Identifier": [],
            "Affiliation": "Bakar Computational Health Sciences Institute, UCSF, San Francisco, CA, USA. marina.sirota@ucsf.edu."
          }
        ],
        "LastName": "Sirota",
        "ForeName": "Marina",
        "Initials": "M"
      }
    ],
    "GrantList": [
      {
        "GrantID": "T32 AI007334",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "T32 GM007618",
        "Acronym": "GM",
        "Agency": "NIGMS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "5DP1DA038043",
        "Acronym": "NH",
        "Agency": "NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "DP1 DA038043",
        "Acronym": "DA",
        "Agency": "NIDA NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U19 AI135972",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Sci Rep",
    "NlmUniqueID": "101563288",
    "ISSNLinking": "2045-2322"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Res Sq. 2021 Mar 30;:",
      "PMID": "33821262"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Computational Biology"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Drug Repositioning"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Transcriptome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    }
  ],
  "CoiStatement": "M.S. is on the advisory board of twoXAR. The Garc\u00eda-Sastre Laboratory has received research support from Pfizer, Senhwa Biosciences and 7Hills Pharma. A.G.S. has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Accurius and Esperovax. Other authors declare no competing financial interests."
}